-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Intellipharmaceutics International Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q1 2020 to Q3 2023.
- Intellipharmaceutics International Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending August 31, 2023 was $241K.
- Intellipharmaceutics International Inc. Net Cash Provided by (Used in) Operating Activities for the twelve months ending August 31, 2023 was $120K.
- Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$1.39M, a 43.6% increase from 2021.
- Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$2.46M, a 2295% decline from 2020.
- Intellipharmaceutics International Inc. annual Net Cash Provided by (Used in) Operating Activities for 2020 was $112K.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)